C. Reichel et al., CHARACTERIZATION OF CYCLOSPORINE-A UPTAKE IN HUMAN ERYTHROCYTES, European Journal of Clinical Pharmacology, 46(5), 1994, pp. 417-419
More than 70% of cyclosporine A (CsA) is bound to erythrocytes at whol
e blood concentrations of 50-1000 ng.ml(-1). Cytosolic CsA is bound to
the erythrocyte peptidyl-prolyl cis-trans isomerase cyclophilin. Meas
urements of serum CsA levels under clinical conditions are hampered by
a temperature-dependent translocation of CsA into erythrocytes during
cooling of the probes to room temperature. In order to characterize t
he kinetics of CsA uptake and to find a specific uptake inhibitor, we
developed a method to measure the velocity of uptake based on rapid co
oling of the erythrocyte suspension. The total erythrocyte-binding cap
acity for CsA amounted to 43.10(-5) nmol per 10(6) erythrocytes or 2.6
.10(5) molecules per erythrocyte. Whereas the erythrocyte-binding capa
city of CsA was temperature-independent between 10 degrees C and 42 de
grees C, uptake kinetics of CsA were temperature-dependent. The Arrhen
ius plot for CsA uptake in human erythrocytes was linear and no transi
tion temperature between 0 degrees C and 42 degrees C could be detecte
d. Therefore the CsA uptake process in human erythrocytes did not fulf
il the criteria of carrier-mediated transport. This indicates that CsA
diffuses passively into human erythrocytes. Hence, erythrocyte CsA up
take cannot be specifically inhibited.